Page last updated: 2024-08-16

terazosin and finasteride

terazosin has been researched along with finasteride in 54 studies

Research

Studies (54)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	24 (44.44)	18.2507
2000's	23 (42.59)	29.6817
2010's	7 (12.96)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ballard, S; Blagg, J; Fox, D; Kenny, B	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Heinzl, S	1
Konen, JC	1
Geller, J; Kirchenbaum, A; Lepor, H; Levine, AC	1
Kreder, KJ	1
Chmiel, JJ; Hillman, AL; Lowe, FC; McDaniel, RL	1
Ramsey, EW	1
Walsh, PC	1
Barry, MJ; Brawer, MK; Dixon, CM; Gormley, G; Haakenson, C; Lepor, H; Machi, M; Narayan, P; Padley, RJ; Williford, WO	1
Zacks, M	1
Cavanaugh, J; Eason, C; Granneman, GR; Hosmane, B; Locke, C; Samara, EE	1
Frankel, S	1
Eri, LM; Tveter, KJ	1
Bianco, G; Carella, M; Cera, A; Scarale, MG; Sperandeo, G; Sperandeo, M; Viola, M	1
Evans, MF; Frank, J	1
Trinkler, FB	1
Andriole, GL; Catalona, WJ; Keetch, DW; Ratliff, TL	1
Barry, MJ; Haakenson, C; Jones, K; Lepor, H; Williford, WO	1
Chung, M; Hilbert, J; Lawrence, V; Phillips, K; Vashi, V	1
Bergman, JM; Broten, TP; Chang, RS; Chen, TB; Erb, JM; Guare, JP; Huff, JR; Lee, HY; Munson, PM; Nerenberg, JB; O'Malley, S; Schorn, TW; Scott, AL; Thompson, WJ	1
Brawer, MK; Jones, K; Lepor, H; Lin, DW; Williford, WO	1
Albertsen, PC; Girman, CJ; Lowe, FC; Pellissier, JM; Roehrborn, CG	1
Lee, TH	1
Cerrato, PL	1
Clifford, GM; Farmer, RD	1
Caprino, L	1
Borkowski, A; Chon, JK; Glassman, DT; Jacobs, SC; Kyprianou, N	1
De la Rosette, JJ; Farmer, RD; Herings, RM; Leufkens, HG; Man in 't Veld, AJ; Souverein, PC	1
Atwa, MA; Mahassini, SH; Mosli, HA	1
Kaplan, SA	1
Baykara, M; Ciftcioglu, MA; Emreoglu, I; Erdoğru, T; Gulkesen, KH; Koksal, T; Ozbilim, G; Usta, MF	1
Issa, MM; Johnson, TM; Jones, K; Kutner, MH; Lepor, H; Williford, WO	1
Gonzalez, CM; McVary, KT	1
Romics, I	1
Fukabori, Y; Honma, S; Kashiwagi, B; Ono, Y; Shibata, Y; Suzuki, K; Yamanaka, H	1
Barqawi, A; Crawford, ED; Gamito, E; O'Donnell, C	1
Brown, GA; Sussman, DO	1
Doggrell, SA	1
Kirby, R	1
O'Leary, MP	1
Anwarul Islam, AK; Kashem, MA; Kibria, SA; Shameem, IA	1
Jin, J; Kong, CZ; Li, NC; Na, YQ; Qiu, SP; Song, YS; Sun, G; Sun, YC; Sun, YH; Wang, XF; Wu, SL; Ye, ZQ	1
Rich, KT; Safranek, S	1
Adomat, H; Elterman, DS; Fleshner, N; Guns, E; Hersey, K; Lawrentschuk, N; Wood, CA	1
Krome, S	1
Daneshmand, S; Shamie, N; Zhang, Y	1

Reviews

15 review(s) available for terazosin and finasteride

Article	Year
Pharmacological options in the treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship	1997
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Prostatic adenoma: new drugs, new surgical techniques]. Medizinische Monatsschrift fur Pharmazeuten, 1992, Volume: 15, Issue:12 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Androstenes; Azasteroids; Cystoscopes; Doxazosin; Finasteride; Humans; Male; Prazosin; Prostatectomy; Prostatic Hyperplasia; Stents	1992
Therapeutic controversies: clinical treatment of benign prostatic hyperplasia. The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:3 Topics: Adrenergic alpha-Antagonists; Cholestenone 5 alpha-Reductase; Clinical Trials as Topic; Drug Therapy, Combination; Finasteride; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Oxidoreductases; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1995
Measures of Proscar, Hytrin, and Cardura side effects. Neurourology and urodynamics, 1997, Volume: 16, Issue:1 Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia	1997
Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective. Drugs & aging, 1997, Volume: 10, Issue:2 Topics: Adrenergic alpha-Antagonists; Aged; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Prazosin; Prevalence; Prostatectomy; Prostatic Hyperplasia; Severity of Illness Index; Treatment Outcome	1997
Medical therapy for benign prostatic hyperplasia: a review of the literature. European urology, 2000, Volume: 38, Issue:1 Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Indoramin; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2000
[Drugs for the treatment of benign prostatic hypertrophy]. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2000, Volume: 52, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Androgen Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Middle Aged; Muscle, Smooth; Plant Extracts; Prazosin; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Serenoa; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urodynamics	2000
Benign prostatic hyperplasia. The Saudi perspective in the year 2000. Saudi medical journal, 2000, Volume: 21, Issue:10 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Age Distribution; Age of Onset; Aged; Finasteride; Humans; Male; Mass Screening; Middle Aged; Needs Assessment; Population Surveillance; Prazosin; Prostatectomy; Prostatic Hyperplasia; Risk Factors; Saudi Arabia; Treatment Outcome; Urology; Workload	2000
5alpha-reductase inhibitors: what role should they play? Urology, 2001, Volume: 58, Issue:6 Suppl 1 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prazosin; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic	2001
The role of combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Current urology reports, 2003, Volume: 4, Issue:4 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Disease Progression; Doxazosin; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia; Treatment Outcome	2003
[Pharmacologic treatment of benign prostatic hyperplasia]. Orvosi hetilap, 2003, Sep-14, Volume: 144, Issue:37 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2003
Treatment and pharmacologic management of BPH in the context of common comorbidities. The American journal of managed care, 2006, Volume: 12, Issue:5 Suppl Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome	2006
FPIN's clinical inquiries. Medical treatment of benign prostatic hyperplasia. American family physician, 2008, Mar-01, Volume: 77, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Antineoplastic Agents; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Practice Guidelines as Topic; Prazosin; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Treatment Outcome	2008
[How effective is finasteride?]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:8 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Drug Therapy, Combination; Finasteride; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin	2011

Trials

11 trial(s) available for terazosin and finasteride

Article	Year
Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia. Urology, 1995, Volume: 46, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Decision Trees; Enzyme Inhibitors; Finasteride; Health Care Costs; Humans; Male; Middle Aged; Models, Economic; Prazosin; Prostatectomy; Prostatic Hyperplasia; Severity of Illness Index	1995
The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. The New England journal of medicine, 1996, Aug-22, Volume: 335, Issue:8 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Oxidoreductases; Prazosin; Prostatic Hyperplasia; Treatment Outcome; Urodynamics	1996
Terazosin vs finasteride for BPH. The Journal of family practice, 1996, Volume: 43, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Drug Combinations; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Placebos; Prazosin; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome; Urination	1996
Assessment of the pharmacokinetic-pharmacodynamic interaction between terazosin and finasteride. Journal of clinical pharmacology, 1996, Volume: 36, Issue:12 Topics: Adrenergic alpha-Antagonists; Adult; Area Under Curve; Blood Pressure; Dihydrotestosterone; Drug Interactions; Enzyme Inhibitors; Finasteride; Half-Life; Heart Rate; Humans; Male; Middle Aged; Prazosin; Testosterone	1996
[Therapy of benign prostatic hyperplasia: terazosin or finasteride?]. Praxis, 1997, Aug-20, Volume: 86, Issue:34 Topics: Adrenergic alpha-Antagonists; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Male; Prazosin; Prospective Studies; Prostatic Hyperplasia; Urodynamics	1997
The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. The Journal of urology, 1998, Volume: 160, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quality of Life; Severity of Illness Index; Treatment Outcome	1998
Pharmacokinetic interaction between finasteride and terazosin, but not finasteride and doxazosin. Journal of clinical pharmacology, 1998, Volume: 38, Issue:11 Topics: Adrenergic alpha-Antagonists; Adult; Area Under Curve; Doxazosin; Drug Interactions; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prazosin; Time Factors	1998
Effect of finasteride and/or terazosin on serum PSA: results of VA Cooperative Study #359. The Prostate, 1999, Jun-01, Volume: 39, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prazosin; Prostate-Specific Antigen; Prostatic Hyperplasia; Treatment Outcome; United States; United States Department of Veterans Affairs	1999
Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. The Journal of urology, 2003, Volume: 170, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quality of Life; Urination Disorders	2003
Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:5 Topics: Clinical Trials as Topic; Doxazosin; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2004
[Comparison of different drugs on the treatment of benign prostate hyperplasia]. Zhonghua wai ke za zhi [Chinese journal of surgery], 2007, Jul-15, Volume: 45, Issue:14 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Androstadienes; Double-Blind Method; Doxazosin; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Plant Extracts; Prazosin; Prostate; Prostatic Hyperplasia; Quality of Life; Secale; Sulfonamides; Tamsulosin; Treatment Outcome	2007

Other Studies

28 other study(ies) available for terazosin and finasteride

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Men's health issues. Archives of family medicine, 1993, Volume: 2, Issue:9 Topics: Adrenergic alpha-Antagonists; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms	1993
Combination drug therapy for benign prostatic hyperplasia. JAMA, 1995, Jul-26, Volume: 274, Issue:4 Topics: Adrenergic alpha-Antagonists; Drug Synergism; Drug Therapy, Combination; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia	1995
Transurethral resection of the prostate: still the gold standard? Canadian journal of surgery. Journal canadien de chirurgie, 1993, Volume: 36, Issue:1 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Adult; Aged; Androstenes; Azasteroids; Catheterization; Finasteride; Humans; Hyperthermia, Induced; Incidence; Male; Middle Aged; Prazosin; Prostatectomy; Prostatic Hyperplasia	1993
Treatment of benign prostatic hyperplasia. The New England journal of medicine, 1996, Aug-22, Volume: 335, Issue:8 Topics: Adrenergic alpha-Antagonists; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Oxidoreductases; Prazosin; Prostatic Hyperplasia	1996
Study provides head-to-head comparison of terazosin, finasteride. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996, Oct-15, Volume: 53, Issue:20 Topics: Adrenergic alpha-Antagonists; Cholestenone 5 alpha-Reductase; Drug Therapy, Combination; Finasteride; Humans; Male; Oxidoreductases; Prazosin; Prostatic Hyperplasia	1996
[Ureteral jet in patients with benign prostatic hypertrophy: prognostic evaluation during single and combined therapy]. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 1996, Volume: 68, Issue:5 Suppl Topics: Adrenergic alpha-Antagonists; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Ultrasonography, Doppler, Color; Urethra; Urination	1996
What is the best medical treatment for benign prostate hyperplasia? Canadian family physician Medecin de famille canadien, 1997, Volume: 43 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Drug Therapy, Combination; Family Practice; Finasteride; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Treatment Outcome	1997
Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting. Urology, 1997, Volume: 50, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Drug Evaluation; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prazosin; Prostate-Specific Antigen; Prostatic Hyperplasia; Retrospective Studies; Statistics, Nonparametric	1997
Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists. Bioorganic & medicinal chemistry letters, 1998, Sep-22, Volume: 8, Issue:18 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Alkylation; Animals; Aorta; Cell Line; CHO Cells; Cricetinae; Dogs; Drug Design; Finasteride; Humans; In Vitro Techniques; Male; Models, Chemical; Prazosin; Prostate; Rats; Receptors, Adrenergic, alpha-1; Saccharin; Structure-Activity Relationship; Sulfonamides; Tamsulosin	1998
Economic analysis of finasteride: a model-based approach using data from the Proscar Long-Term Efficacy and Safety Study. Clinical therapeutics, 1999, Volume: 21, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Decision Trees; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Models, Economic; Prazosin; Prostate-Specific Antigen; Prostatic Hyperplasia; Randomized Controlled Trials as Topic	1999
By the way, doctor... I'm 78 and have more and more difficulty urinating. I get up three times a night - sometimes more - to go to the bathroom and it takes me a while to start urinating and even longer to stop. I know that this is probably a prostate pro Harvard health letter, 1999, Volume: 24, Issue:12 Topics: Adrenergic alpha-Antagonists; Aged; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	1999
Diet and herbs for BPH? RN, 2000, Volume: 63, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia	2000
Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia. The Prostate, 2001, Jan-01, Volume: 46, Issue:1 Topics: Adrenergic alpha-Antagonists; Antibodies, Monoclonal; Apoptosis; Cell Division; Drug Combinations; Enzyme Inhibitors; Finasteride; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Ki-67 Antigen; Linear Models; Male; Prazosin; Prostate; Prostatic Hyperplasia; Receptors, Transforming Growth Factor beta; Regression Analysis; Retrospective Studies; Transforming Growth Factor beta	2001
Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations. Journal of clinical epidemiology, 2001, Volume: 54, Issue:5 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Adult; Aged; Bias; Cardiovascular Diseases; Case-Control Studies; Finasteride; Humans; Male; Middle Aged; Morbidity; Netherlands; Prazosin; Prognosis; Prostatic Hyperplasia; Quinazolines; Research Design; Risk Factors; Sulfonamides; Tamsulosin	2001
Apoptotic and proliferative index after Alpha-1-adrenoceptor antagonist and/or finasteride treatment in benign prostatic hyperplasia. Urologia internationalis, 2002, Volume: 69, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Retrospective Studies	2002
Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate. Urology, 2003, Volume: 62, Issue:5 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Androgen Antagonists; Anilides; Animals; Capillaries; Chlormadinone Acetate; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hormone Antagonists; Male; Microcirculation; Nitriles; Prazosin; Prostate; Rats; Rats, Wistar; Sulfonamides; Tamsulosin; Testosterone; Tosyl Compounds	2003
Herbal and vitamin supplement use in a prostate cancer screening population. Urology, 2004, Volume: 63, Issue:2 Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Adult; Aged; Colorado; Complementary Therapies; Dietary Supplements; Doxazosin; Drug Utilization; Family; Finasteride; Health Surveys; Humans; Male; Mass Screening; Middle Aged; Penile Erection; Phytotherapy; Plant Preparations; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms; Self Medication; Socioeconomic Factors; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders; Vitamins	2004
A current review of medical therapy for benign prostatic hyperplasia. The Journal of the American Osteopathic Association, 2004, Volume: 104, Issue:2 Suppl 2 Topics: Adrenergic alpha-Antagonists; Algorithms; Azasteroids; Cholestenone 5 alpha-Reductase; Doxazosin; Drug Therapy, Combination; Dutasteride; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Urination Disorders	2004
Meta-analysis: creating a level playing field for the patient with symptomatic benign prostatic hyperplasia? BJU international, 2004, Volume: 94, Issue:1 Topics: Antineoplastic Agents; Catheter Ablation; Finasteride; Humans; Male; Meta-Analysis as Topic; Prazosin; Prostatic Hyperplasia	2004
Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study. Bangladesh Medical Research Council bulletin, 2005, Volume: 31, Issue:2 Topics: Adrenergic alpha-Antagonists; Aged; Bangladesh; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Treatment Outcome	2005
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors. The Journal of urology, 2010, Volume: 183, Issue:5 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Azasteroids; Capsules; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Doxazosin; Drug Contamination; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tablets; Tamsulosin	2010
Assessment of Urologists' Knowledge of Intraoperative Floppy Iris Syndrome. Urology, 2016, Volume: 97 Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Competence; Fellowships and Scholarships; Female; Finasteride; Health Knowledge, Attitudes, Practice; Humans; Internship and Residency; Intraoperative Complications; Iris Diseases; Male; Medical Staff, Hospital; Ophthalmology; Patient Education as Topic; Prazosin; Prostatic Hyperplasia; Referral and Consultation; Sulfonamides; Surveys and Questionnaires; Syndrome; Tamsulosin; Urological Agents; Urology; Vision Disorders	2016